Teichman, S.L., Unemori, E., Dschietzig, T. et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Fail Rev 14, 321 (2009). https://doi.org/10.1007/s10741-008-9129-3(англ.)
Chen, T-Y, Li, X, Hung, C-H, et al. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease. Mol Genet Genomic Med. 2020; 8:e1194. https://doi.org/10.1002/mgg3.1194
Sarwar M, Du X-J, Dschietzig TB, and Summers RJ (2017). The actions of relaxin on the human cardiovascular system. Br J Pharmacol 174: 933–949. https://doi.org/10.1111/bph.13523(англ.)
